Grail, Inc. (NASDAQ:GRAL – Get Free Report) President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the sale, the president now directly owns 559,673 shares in the company, valued at approximately $17,461,797.60. The trade was a 0.38 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Grail Price Performance
GRAL stock opened at $29.74 on Friday. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99. The company’s 50-day moving average price is $31.81 and its 200 day moving average price is $21.29.
Grail (NASDAQ:GRAL – Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analysts’ expectations of $35.33 million. On average, research analysts expect that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Read Our Latest Stock Report on Grail
Hedge Funds Weigh In On Grail
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Crcm LP acquired a new position in Grail during the fourth quarter worth about $65,061,000. Sessa Capital IM L.P. acquired a new position in Grail during the fourth quarter worth about $53,550,000. Primecap Management Co. CA acquired a new position in Grail during the fourth quarter worth about $37,118,000. Baker BROS. Advisors LP acquired a new position in Grail during the fourth quarter worth about $29,098,000. Finally, Vanguard Group Inc. acquired a new position in Grail during the fourth quarter worth about $25,902,000.
Grail Company Profile
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Articles
- Five stocks we like better than Grail
- What Are Some of the Best Large-Cap Stocks to Buy?
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Growth Stocks: What They Are, Examples and How to Invest
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.